Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinical Cancer Research

• Publication date

  1999-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 10632372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of angiogenesis inhibitors for cancer therapy

  2004cited by this paper
• Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+exchanger isoform NHE3.

  1999cited by this paper
• SQUALAMINE DOWNREGULATES INTEGRIN alphav beta3 EXPRESSION AND OBLITERATES ADVANCED HUMAN PROSTATE CANCER (HPC): A PRECLINICAL STUDY

  1999cited by this paper
• Squalamine: A New Angiostatic Steroid

  1998cited by this paper
• New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.

  1998cited by this paper
• Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.

  1998influential reference
• Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.

  1998influential reference
• Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy.

  1998cited by this paper
• Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.

  1997cited by this paper
• Cancer statistics, 1997

  1997cited by this paper
• Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation.

  1996cited by this paper
• Clinical Applications of Research on Angiogenesis

  1995cited by this paper
• Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.

  1995cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Angiostatic activities of medroxyprogesterone acetate and its analogues

  1994cited by this paper
• Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis

  1994cited by this paper
• Mechanism of action of angiostatic steroids: Suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis

  1993cited by this paper
• Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors.

  1993cited by this paper
• Squalamine: an aminosterol antibiotic from the shark.

  1993cited by this paper
• Medroxyprogesterone acetate, an anti‐cancer and anti‐angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• Inhibition of angiogenesis through modulation of collagen metabolism.

  1988cited by this paper
• Angiostatic steroids. Method of discovery and mechanism of action.

  1987cited by this paper
• Inhibitory effects of heparin plus cortisone acetate on endothelial cell growth both in cultures and in tumor masses.

  1987cited by this paper
• A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.

  1986cited by this paper
• Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma.

  1985cited by this paper
• Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone.

  1981cited by this paper

• Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression

  2022cites this paper
• Evaluation of the effects of cisplatin and the cisplatin-alum mixture as adjuvants for increasing the efficacy of vaccination against Salmonella typhimurium in Balb/c mice

  2021cites this paper
• Synthesis and Biological Activities of Natural Functionalized Polyamines: An Overview.

  2020cites this paper
• Biomedicine developments based on marine biodiversity: present and future

  2020cites this paper
• Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.

  2019cites this paper
• A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth

  2019cites this paper
• Squalamine and age-related macular degeneration. Did the Shark lose its teeth?

  2018cites this paper
• Potential Human Health Applications from Marine Biomedical Research with Elasmobranch Fishes

  2018cites this paper
• Use of amantadine as substrate for SSAT-1 activity as a reliable clinical diagnostic assay for breast and lung cancer

  2018cites this paper
• Synthesis, Antiproliferative, and Cytotoxic Effect of Two New Hydantoin Derivatives on Growth of Mouse Mammary Adenocarcinoma Cell Line (AMN3) (In vitro)

  2018cites this paper
• A colorimetric and far-red fluorescent probe for the highly sensitive detection of silver(I)

  2017cites this paper
• Quaternary Alkylammonium Conjugates of Steroids: Synthesis, Molecular Structure, and Biological Studies

  2015cites this paper
• Promises of the Unprecedented Aminosterol Squalamine

  2014cites this paper
• Trace level determination of precious metals in aqueous medium, U, Th and Zr based nuclear materials by ICP-AES and EDXRF: a comparative study

  2014cites this paper
• Méthodes d'inhibition de la prolifération cellulaire et de traitement de certaines maladies

  2014cites this paper
• Fluorescent chemosensors based on spiroring-opening of xanthenes and related derivatives.

  2012cites this paper
• Simple, selective, and sensitive colorimetric and ratiometric fluorescence/phosphorescence probes for platinum(II) based on Salen-type Schiff bases

  2012cites this paper
• An efficient conjugated polymer sensor based on the aggregation-induced fluorescence quenching mechanism for the specific detection of palladium and platinum ions

  2012cites this paper
• Angiogenesis and Lung Cancer

  2011cites this paper
• Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential

  2011cites this paper
• Recent progress in fluorescent and colorimetric chemosensors for detection of precious metal ions (silver, gold and platinum ions).

  2011cites this paper
• Prediction of proapoptotic anticancer therapeutic response based on visualization of death ligand-receptor interaction and specific marker of cellular proliferation

  2010cites this paper
• Rhodamine triazole-based fluorescent probe for the detection of Pt(2+).

  2010cites this paper
• Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS‐4, a novel pro‐apoptotic gene

  2009cites this paper
• Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.

  2008cites this paper
• Angiogenesis Inhibitors for the Treatment of Lung Cancer

  2008cites this paper
• Identification of squalamine in the plasma membrane of white blood cells in the sea lamprey, Petromyzon marinus Published, JLR Papers in Press, August 28, 2007.

  2007cites this paper
• Targeted therapies for non-small cell lung cancer.

  2007cites this paper
• Clinical aspects of natural anti-angiogenic drugs.

  2006cites this paper
• Enhancement by dexamethasone of the therapeutic benefits of cisplatin via regulation of tumor angiogenesis and cell cycle kinetics in a murine tumor paradigm.

  2006cites this paper
• Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.

  2006cites this paper
• Squalamine: a polyvalent drug of the future?

  2005cites this paper
• A CASE OF EARLY BILE DUCT CARCINOMA REGRESSED BY INGESTION OF SHARK CARTILAGE

  2005cites this paper
• Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid Tumors

  2005cites this paper
• Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy.

  2005cites this paper
• Antiangiogenic Steroids in Human Cancer Therapy

  2005cites this paper
• ImprovedTherapeutic Effectiveness by Combining Recombinant CXCChemokine Ligand 10 with Cisplatin in SolidTumors

  2005cites this paper
• The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.

  2005cites this paper
• GREAT LAKES FISHERY COMMISSION 2004 Project Completion Report 1 Purification and characterization of anti-microbial bioactive peptides from sea lamprey

  2004cites this paper
• Quantitative analysis of squalamine, a self-ionization-suppressing aminosterol sulfate, in human plasma by LC-MS/MS.

  2004cites this paper
• Purification and characterization of anti-microbial bioactive peptides from sea lamprey by :

  2004cites this paper
• Antiangiogenic and antimetastatic properties of Neovastat (Æ-941), an orally active extract derived from cartilage tissue

  2004cites this paper
• Synthesis and antifungal activity of cholesterol-hydrazone derivatives.

  2004cites this paper
• Endothelial cell effects of cytotoxics: balance between desired and unwanted effects.

  2004cites this paper
• Inhibition of angiogenesis at endothelial cell level

  2003influential citation
• Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor.

  2003cites this paper
• Squalamine Lactate Reduces Choroidal Neovascularization in a Laser-Injury Model in the Rat

  2003cites this paper
• A Phase I and Pharmacokinetic Study of Squalamine , an Aminosterol Angiogenesis Inhibitor 1

  2003cites this paper
• DNA-binding agents.

  2003cites this paper
• Targeted therapy for lung cancer

  2003cites this paper
• The role of growth factor signaling in malignancy.

  2003cites this paper
• A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.

  2003cites this paper
• Determination of degradation products of squalamine lactate using LC/MS.

  2003cites this paper
• A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor.

  2003cites this paper
• Inhibitors of Angiogenesis

  2002cites this paper
• Anti-angiogenic agents for the treatment of brain tumors.

  2002cites this paper
• DNA-binding agents.

  2002cites this paper
• Sharks: A Potential Source of Antiangiogenic Factors and Tumor Treatments

  2002cites this paper
• Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer

  2002cites this paper
• Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target?

  2002cites this paper
• Angiogenesis in Non-Small Cell Lung Cancer

  2002cites this paper
• EFFECT OF SQUALAMINE ON IRIS NEOVASCULARIZATION IN MONKEYS

  2002cites this paper
• Novel targets for lung cancer therapy: part I.

  2002cites this paper
• Three-dimensional angioarchitecture in transplantable rat fibrosarcomas.

  2002cites this paper
• Novel therapies for lung cancer.

  2002cites this paper
• Promising developments in targeted therapies for non-small-cell lung cancer.

  2002cites this paper
• Novel targets for lung cancer therapy: part II.

  2002cites this paper
• Synthesis and antimicrobial activity of new 3α-Hydroxy-23,24-bisnorcholane polyamine carbamates

  2001cites this paper
• A new highly stereoselective construction of the sidechain of squalamine through improved Sharpless catalytic asymmetric dihydroxylation

  2001cites this paper
• Suppression of Tumor Angiogenesis by Nonsteroidal Anti-Inflammatory Drugs: A New Function for Old Drugs

  2001cites this paper
• Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.

  2001cites this paper
• The use of chemotherapy to facilitate surgical resection in pleomorphic xanthoastrocytoma: experience in a single case

  2001cites this paper
• Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma.

  2001cites this paper
• A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.

  2001cites this paper
• Tumor angiogenesis as a therapeutic target.

  2001cites this paper
• Synthesis and antimicrobial activity of new 3 alpha-hydroxy-23,24-bisnorcholane polyamine carbamates.

  2001cites this paper
• Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies.

  2001cites this paper
• Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.

  2001cites this paper
• Antiangiogenesis therapy. Current and future agents.

  2001cites this paper
• Introduction

  1998cites this paper